+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Bone Cement Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 180 Pages
  • August 2024
  • Region: North America
  • Expert Market Research
  • ID: 5934579
The North America bone cement market was valued at USD 349.02 million in 2023, driven by the increasing number of joint replacement surgeries and rising advancements in bone cement formulations in the region. The market is expected to grow at a CAGR of 5.80% during the forecast period of 2024-2032, reaching a value of USD 579.72 million by 2032.

North America Bone Cement Market Analysis

The North America bone cement market is a crucial segment within the orthopaedic industry, primarily driven by the increasing prevalence of orthopaedic surgeries and the rising elderly population. Bone cement, a key component in joint replacement surgeries, offers stability and durability to orthopaedic implants, thereby facilitating faster post-operative recovery.

Market Drivers

Several factors propel the growth of the North America bone cement market:

  • Rising Geriatric Population: The ageing population is prone to orthopaedic ailments such as osteoarthritis and fractures, necessitating joint replacement surgeries.
  • Technological Advancements: Innovations in bone cement formulations and delivery systems enhance surgical outcomes, driving market demand.
  • Increasing Orthopaedic Surgeries: Growing awareness and accessibility to healthcare services contribute to a higher number of joint replacement procedures.
  • Healthcare Infrastructure Development: Investments in healthcare infrastructure and facilities support the adoption of advanced orthopaedic treatments.

Challenges

Despite its growth prospects, the North America bone cement market faces several challenges:

  • Regulatory Compliance: Stringent regulatory requirements for medical devices and implants can impact market entry and product approvals.
  • Cost Constraints: High costs associated with orthopaedic surgeries and implants may limit adoption rates, particularly among uninsured or underinsured patients.
  • Competitive Market Landscape: Intense competition among key market players necessitates continuous innovation and strategic pricing strategies.

Future Opportunities

The future outlook for the North America bone cement market remains promising, with opportunities arising from:
  • Advancements in Biomaterials: Development of bioactive and biodegradable bone cements that enhance biocompatibility and reduce post-operative complications.
  • Expansion of Minimally Invasive Techniques: Increasing preference for minimally invasive surgeries offers potential growth avenues for bone cement applications.
  • Focus on Patient Outcomes: Emphasis on patient-centric care and personalised medicine drives demand for improved bone cement formulations and surgical techniques.

North America Bone Cement Market Trends

The North America bone cement market is witnessing dynamic trends that are reshaping the orthopaedic landscape. Key trends include:
  • Shift towards Biocompatible Formulations: There is a notable trend towards biocompatible bone cement formulations, aimed at reducing complications and enhancing patient outcomes post-surgery.
  • Rise of Minimally Invasive Procedures: Increasing adoption of minimally invasive surgical techniques is driving demand for bone cement, as these procedures offer quicker recovery times and reduced hospital stays.
  • Integration of Digital Health Technologies: The integration of digital health technologies, such as augmented reality (AR) and robotic-assisted surgeries, is influencing surgical precision and the application of bone cement in orthopaedic procedures.
  • Focus on Sustainability: Growing environmental concerns are prompting manufacturers to develop sustainable bone cement options, aligning with global efforts towards eco-friendly healthcare solutions.
  • Market Consolidation and Strategic Partnerships: The market is witnessing consolidation through mergers and acquisitions, as well as strategic partnerships between pharmaceutical companies and orthopaedic device manufacturers.
These trends underscore the evolving nature of the North America bone cement market, presenting opportunities for innovation and growth amidst a competitive landscape.

North America Bone Cement Market Segmentation

Market Breakup by Product

  • Calcium Phosphate Cement (CPC)
  • Glass Polyalkenoate Cement
  • Polymethyl Methacrylate (PMMA) Cement
The North America bone cement market is segmented into key products: Calcium Phosphate Cement (CPC), Glass Polyalkenoate Cement, and Polymethyl Methacrylate (PMMA) Cement. PMMA cement dominates due to its established efficacy in joint replacement surgeries, driven by the rising elderly population and advancements in orthopaedic procedures. CPC is poised for significant growth, supported by its biocompatibility and potential for minimally invasive applications. Glass Polyalkenoate Cement is also gaining traction with innovations in dental and orthopaedic applications. These segments are expected to fuel market expansion, leveraging technological advancements and increasing surgical volumes in the forecast period.

Market Breakup by Application

  • Kyphoplasty
  • Arthroplasty
  • Vertebroplasty
The North America bone cement market is segmented by application into Kyphoplasty, Arthroplasty, and Vertebroplasty. Arthroplasty, encompassing joint replacement surgeries, drives significant market growth due to the ageing population and increasing incidence of osteoarthritis. Kyphoplasty, used in vertebral compression fractures, is poised for expansion with advancements in minimally invasive techniques. Vertebroplasty, involving the stabilization of vertebral fractures, benefits from technological innovations enhancing surgical outcomes. These applications represent key drivers for market expansion, supported by rising healthcare investments and patient demand for improved orthopaedic treatments in the region.

Market Breakup by End User

  • Hospital
  • Ambulatory Surgical Centres
  • Clinics
The North America bone cement market is segmented by end-user into Hospitals, Ambulatory Surgical Centres (ASCs), and Clinics. Hospitals dominate the market due to their advanced infrastructure and high patient footfall for orthopaedic surgeries like joint replacements. Ambulatory Surgical Centres are gaining traction for their convenience and cost-effectiveness, particularly for outpatient procedures such as kyphoplasty and arthroscopy. Clinics play a vital role in providing specialised orthopaedic care and post-operative rehabilitation services, contributing to market growth through enhanced patient accessibility and personalised treatment options across the forecast period.

Market Breakup by Country

  • United States
  • Canada
The North America bone cement market is segmented by country into the United States and Canada. The United States leads the market due to its large population base, high prevalence of orthopaedic disorders, and advanced healthcare infrastructure supporting extensive surgical procedures. Canada follows with a growing demand for orthopaedic treatments driven by an ageing population and increasing healthcare expenditures. Both countries exhibit opportunities for market growth through technological advancements, rising surgical volumes, and efforts towards improving patient outcomes in orthopaedic care across the forecast period.

North America Bone Cement Market Competitive Landscape

The competitive landscape of the North America bone cement market is marked by leading players including Johnson & Johnson MedTech (Depuy Synthes), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Medtronic plc, DJO, LLC, Globus Medical, Inc., Arthrex, Inc., Cardinal Health, Inc., and Heraeus Medical LLC. These companies engage in frequent mergers and acquisitions to expand their product portfolios and market reach. Research initiatives focus on developing advanced bone cement formulations and surgical techniques. Product introductions are common, aimed at meeting evolving clinical needs and enhancing surgical outcomes. Partnerships with healthcare providers and academic institutions drive innovation and market penetration. This competitive landscape underscores continuous efforts towards innovation and strategic collaborations to maintain leadership and capture growth opportunities in the orthopaedic industry.

Key Questions Answered in the Report

  • What is the current and future performance of the bone cement market?
  • What are the main challenges facing the bone cement market?
  • What are the key drivers of the bone cement market?
  • What emerging trends are shaping the future of the bone cement market?
  • How do innovations in bone cement formulations improve surgical outcomes in orthopaedics?
  • Why does PMMA cement dominate in joint replacement surgeries despite advancements in orthopaedic procedures?
  • How are advancements in minimally invasive techniques influencing the expansion of kyphoplasty and vertebroplasty procedures?
  • What factors are driving the growing demand for orthopaedic treatments in Canada?
  • What are the common strategies used by key players in the bone cement market?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the North America bone cement market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the North America bone cement market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the bone cement industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Bone Cement Market Overview
3.1 Global Bone Cement Market
3.1.1 Global Bone Cement Market Historical Value (2017-2023)
3.1.2 Global Bone Cement Market Forecast Value (2024-2032)
3.2 North America Bone Cement Market
3.2.1 North America Bone Cement Market Historical Value (2017-2023)
3.2.2 North America Bone Cement Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 North America Bone Cement Market Landscape*
5.1 North America Bone Cement: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Country
5.2 North America Bone Cement: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Application
6 North America Bone Cement Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 North America Bone Cement Market Segmentation (2017-2032)
7.1 North America Bone Cement Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Calcium Phosphate Cement (CPC)
7.1.3 Glass Polyalkenoate Cement
7.1.4 Polymethyl Methacrylate (PMMA) Cement
7.2 North America Bone Cement Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Kyphoplasty
7.2.3 Arthroplasty
7.2.4 Vertebroplasty
7.3 North America Bone Cement Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospital
7.3.3 Ambulatory Surgical Centres
7.3.4 Clinics
7.4 North America Bone Cement Market (2017-2032) by Country
7.4.1 Market Overview
7.4.2 United States
7.4.3 Canada
8 United States Bone Cement Market Segmentation (2017-2032)
8.1 United State Bone Cement Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Calcium Phosphate Cement (CPC)
8.1.3 Glass Polyalkenoate Cement
8.1.4 Polymethyl Methacrylate (PMMA) Cement
8.2 United State Bone Cement Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Kyphoplasty
8.2.3 Arthroplasty
8.2.4 Vertebroplasty
8.3 United State Bone Cement Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospital
8.3.3 Ambulatory Surgical Centres
8.3.4 Clinics
9 Canada Bone Cement Market Segmentation (2017-2032)
9.1 Canada Bone Cement Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Calcium Phosphate Cement (CPC)
9.1.3 Glass Polyalkenoate Cement
9.1.4 Polymethyl Methacrylate (PMMA) Cement
9.2 Canada Bone Cement Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Kyphoplasty
9.2.3 Arthroplasty
9.2.4 Vertebroplasty
9.3 Canada Bone Cement Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospital
9.3.3 Ambulatory Surgical Centres
9.3.4 Clinics
10 Regulatory Framework
10.1 Regulatory Overview
10.2 US FDA
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication Year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Funding and Investment Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Strategic Initiative
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share Analysis, By Region (Top 5 Companies)
14.1.1 Market Share Analysis: North America
14.2 Johnson & Johnson MedTech (Depuy Synthes)
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 Stryker Corporation
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 Zimmer Biomet Holdings, Inc
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Smith & Nephew plc
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 Medtronic plc
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 DJO, LLC
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Globus Medical, Inc.
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 Arthrex, Inc.
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 Cardinal Health, Inc.
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic Reach and Achievements
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Heraeus Medical LLC
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
15 North America Bone Cement Market - Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Johnson & Johnson MedTech (Depuy Synthes)
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc
  • Smith & Nephew plc
  • Medtronic plc
  • DJO, LLC
  • Globus Medical, Inc
  • Arthrex, Inc.
  • Cardinal Health, Inc.
  • Heraeus Medical LLC

Methodology

Loading
LOADING...

Table Information